For the first time, an expensive vaccine aimed at preventing cervical cancer in women has proven successful at preventing a disease in men, according to a study released Thursday by the vaccine’s ...

October 19, 2009 — The US Food and Drug Administration (FDA) has approved a new indication for a quadrivalent recombinant vaccine (Gardasil, Merck & Company, Inc) for the prevention of condyloma ...

NEW YORK (Reuters Health) - Men who carry the virus that causes genital warts may be at increased risk of HIV infection, a study of Kenyan men suggests. Researchers say the findings raise the ...

The FDA has approved Gardasil (human papillomavirus quadrivalent [types 6, 11, 16, and 18] vaccine, recombinant, from Merck) for the prevention of genital warts caused by human papillomavirus (HPV) ...

HealthDay News — The current quadrivalent human papillomavirus (HPV) vaccine does not have a significant impact on the recurrence of genital warts in men exposed to HPV infection, according to ...

While most human papillomavirus (HPV) infection clears on its own, persistent HPV infection can cause genital warts and anal, penile and oropharyngeal cancers in men. Dr. Sadeep Shrestha, associate ...

Sexually transmitted diseases are on the rise. A new report in The Lancet Global Health has indicated that around the world, nearly one in three men over age 15 are infected with at least one type of ...

A new study in JAMA Oncology shows that nearly half of all men in the U.S. have some type of human papillomavirus infection. HPV is a common sexually transmitted infection that is a major cause of ...

Background: Medical therapy for genital warts remains suboptimal. The topical interférai and cytokine inducer, imiquimod, has been proved effective for the treatment of external genital and perianal ...

WASHINGTON -- Drugmaker Merck said Friday that U.S. regulators cleared its vaccine Gardasil to prevent genital warts in young males, a new use for a product already approved to prevent cervical cancer ...